Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Licenses His Tag Protein Purification Patent to Biogen

NEW YORK, Oct. 7 (GenomeWeb News) - Inproteo (formerly known as the Indiana Proteomics Consortium) said today that it has licensed US Patent No. 4,569,794 -- which protects a fusion protein purification technique known commonly as "His Tag" -- to Biogen.

"This license allows Biogen to have complete use of the technology for their research, development and commercialization activities," said Dr. John Hurrell, president of Inproteo.

Eli Lilly and Company, the original assignee on the patent, granted a license to Inproteo with exclusive right to issue sub-licenses, Inproteo said.

Inproteo said that a number of life science and biopharmaceutical companies have already concluded a licensing agreement and that the consortium is "holding discussions with numerous other companies, research institutes, and universities to license the patent for research and commercial use."

Inproteo was founded in 2002 as a collaboration between Indiana University, Purdue University, and Eli Lilly and Company.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.